Empagliflozin Improves Heart Failure Caused by Pressure Overload by Regulating Cardiac Metabolism

被引：0
|
作者：
Li, Xuan
Liu, Jia
Ren, Di
Zhang, Jingwen
Han, Ying
Li, Ji
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10294
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] γδ T Cells Mediate Pressure Overload -Induced Cardiac Inflammation, Hypertrophy, Heart Failure Development, and Heart Failure Progression
    Bhattarai, Umesh
    He, Xiaochen
    Pan, Lihong
    Niu, Ziru
    Wang, Dongzhi
    Chen, Yingjie
    PHYSIOLOGY, 2024, 39
  • [42] Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model
    Okawa, Yoshifumi
    Hoshino, Atsushi
    Ariyosht, Makoto
    Kaimoto, Satoshi
    Tateishi, Shuhei
    Ono, Kazunori
    Uchihashi, Motoki
    Iwai-Kanai, Eri
    Matoba, Satoaki
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2019, 316 (06): : H1366 - H1377
  • [43] Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure
    Patel, Bindiya
    Ismahil, Mohamed Ameen
    Hamid, Tariq
    Bansal, Shyam S.
    Prabhu, Sumanth D.
    PLOS ONE, 2017, 12 (01):
  • [44] Drug repurposing to prevent pressure overload-induced cardiac hypertrophy and heart failure
    Tual-Chalot, Simon
    Stellos, Konstantinos
    EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3783 - 3785
  • [45] MYOSTATIN INHIBITION IMPROVES CARDIAC GLUCOSE METABOLISM IN A MURINE MODEL OF HEART FAILURE
    Castillero, Estibaliz
    Akashi, Hirokazu
    Ji, Ruiping
    Wang, Catherine
    Ali, Ziad
    Sweeney, H. Lee
    Schulze, P. Christian
    George, Isaac
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1626 - A1626
  • [46] DGK ζ prevents pressure overload-induced cardiac hypertrophy and progression to heart failure
    Harada, Mutsuo
    Arimoto, Takanori
    Takeishi, Yasuchika
    CIRCULATION, 2006, 114 (18) : 54 - 55
  • [47] Cardiac-specific overexpression of GLUT1 improves survival and prevents the development of heart failure secondary to pressure overload in mice
    Jain, M
    Liao, R
    Cui, L
    D'Agostoni, J
    Aiello, F
    Lupak, I
    Ngoy, S
    Mortensen, RM
    Tian, R
    CIRCULATION, 2002, 106 (19) : 306 - 306
  • [48] Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure.
    Shiraki, Aya
    Oyama, Jun-ichi
    Shimizu, Takahiko
    Nakajima, Takayuki
    Yokota, Takashi
    Node, Koichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931
  • [49] Short- and Long-Term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure
    Soulie, Matthieu
    Stephan, Yohan
    Nicol, Lionel
    Henry, Jean-Paul
    Richard, Vincent
    Pieper, Michael
    Mulder, Paul
    DIABETES, 2020, 69
  • [50] ChGn-2 Plays a Cardioprotective Role in Heart Failure Caused by Acute Pressure Overload
    Haryono, Andreas
    Ikeda, Koji
    Nugroho, Dhite Bayu
    Ogata, Takehiro
    Tsuji, Yumika
    Matoba, Satoaki
    Moriwaki, Kensuke
    Kitagawa, Hiroshi
    Igarashi, Michihiro
    Hirata, Ken-ichi
    Emoto, Noriaki
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (07):
12345